Results 1 to 10 of about 449,446 (158)
Thoracic Cancer, 2023 IgG4‐related diseases are adverse events that occur after receiving treatment with immune checkpoint inhibitors (ICI). This study reports the first case of IgG4‐related retroperitoneal fibrosis after the administration of chemotherapy with nivolumab and ...
Masashi Nishimura +13 more
semanticscholar +2 more sources
Current approach to diagnosis and management of retroperitoneal fibrosis
International Journal of Urology, 2020 Retroperitoneal fibrosis is characterized by fibrotic lesions around the abdominal aorta and common ileac artery causing ureteral obstruction. Secondary retroperitoneal fibrosis is associated with malignant disease, drugs, exposure to radiation and ...
Toshiaki Tanaka, Naoya Masumori
exaly +2 more sources
PLoS ONE, 2021 Retroperitoneal fibrosis (RPF) is an uncommon condition characterized by inflammation and fibrosis in the retroperitoneal space. More than two-thirds of RPF are idiopathic, with the remaining stemed from a variety of secondary causes.
Kunkun Wang +10 more
semanticscholar +2 more sources
Combined therapy of prednisone and mTOR inhibitor sirolimus for treating retroperitoneal fibrosis
Annals of the Rheumatic Diseases, 2022 Objectives Retroperitoneal fibrosis (RPF) is a rare autoimmune disease with fibrous tissue growth and inflammation in retroperitoneum. Its current treatments involve long-term uptake of glucocorticoids (e.g., prednisone) for controlling inflammation ...
Hui Gao +7 more
semanticscholar +1 more source
IgG4‐related retroperitoneal fibrosis: a newly characterized disease
International Journal of Rheumatic Diseases, 2016 Linjuan Lian +2 more
exaly +2 more sources
Retroperitoneal Fibrosis Is Still an Underdiagnosed Entity with Poor Prognosis
Kidney & Blood Pressure Research, 2021 Background: Retroperitoneal fibrosis (RPF) is a rare disease characterized by the presence of inflammatory and fibrous retroperitoneal tissue that often encircles abdominal organs including the aorta and ureters. Data on the incidence of this disease are
Izabela Łoń +3 more
semanticscholar +1 more source
Renal Involvement in Retroperitoneal Fibrosis: Prevalence, Impact and Management Challenges
International Journal of Nephrology and Renovascular Disease, 2021 Retroperitoneal fibrosis (RPF) is a rare disorder consisting of idiopathic and various secondary forms and characterized by chronic inflammatory infiltrates and marked fibrosis in the retroperitoneal space.
I. Mizushima, M. Kawano
semanticscholar +1 more source
Association of retroperitoneal fibrosis with malignancy and its outcomes
Arthritis Research & Therapy, 2021 Introduction Retroperitoneal fibrosis (RPF) is characterized by a highly fibrotic retroperitoneal mass and encompasses the idiopathic form and secondary to malignancies.
Sang Jin Lee +4 more
semanticscholar +1 more source
Idiopathic retroperitoneal fibrosis: an update for nephrologists.
Nephrology, Dialysis and Transplantation, 2020 Idiopathic retroperitoneal fibrosis (IRF) is a rare condition characterized by the development of a peri-aortic and peri-iliac tissue showing chronic inflammatory infiltrates and pronounced fibrosis.
Valentina Raglianti +2 more
semanticscholar +1 more source
RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, 2020 Background Retroperitoneal fibrosis is a rare disease with an incidence of 0–1/100 000 inhabitants per year and is associated with chronic inflammatory fibrosis of the retroperitoneum and the abdominal aorta.
F. Peisen +7 more
semanticscholar +1 more source